🔎 Trials Near Me

Beranda › Sarkoma Jaringan Lunak › Distrik Columbia › Washington

Uji klinis Sarkoma Jaringan Lunak di Washington, DC

12 studi untuk Sarkoma Jaringan Lunak mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
4 Weeks · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01109394

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

Menerima pesertaFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06865664

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Menerima pesertaFase 1
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT05711615

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Menerima pesertaFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 3 hingga 35 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT02390752

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

Menerima peserta
  • Sibley Memorial Hospital, Washington D.C.
Hingga usia 39 · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT06796543

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Menerima pesertaFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT04901702

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Menerima pesertaFase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT06503146

Pre-operative Hypofractionated Proton Therapy

Menerima peserta
  • Sibley Memorial Hospital, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT05917301

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Menerima pesertaFase 1/2
  • Children's National Hospital, Washington D.C.
Usia 2 hingga 30 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05734066

Pediatric Radiation Therapy Registry

Menerima pesertaStudi observasional
  • Sibley Memorial Hospital, Washington D.C.
Usia 0 hingga 26 · Semua jenis kelamin · Diperbarui 5 Nov 2025 · NCT07129317

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Menerima pesertaFase 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT05135975

Uji klinis Sarkoma Jaringan Lunak di kota lain

Studi lain di Washington

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.